COVID-19

From Bench to Bedside

Häftad, Engelska, 2022

Av Debmalya Barh, Kenneth Lundstrom, Brazil.) Barh, Debmalya (UFMG, Switzerland) Lundstrom, Kenneth (PanTherapeutics

829 kr

Skickas torsdag 13/11

Fri frakt för medlemmar vid köp för minst 249 kr.

The COVID-19 pandemic has affected the entire world in an unprecedented way, and this book provides an overview of the historical facts as well as ongoing approaches to tackle the COVID-19 pandemic. Experts of the respective domains provide details on anti-SARS-CoV-2 drug strategies, including repurposing drugs used for other indications and the development of novel drugs looking at different approaches to target virus entry and replication. COVID-19 vaccine development based on inactivated and attenuated live virus, protein subunit and peptide-based vaccines and utilization of vaccine candidates based on viral vectors, DNA and RNA are presented for both preclinical studies and clinical trials. Key Features Explains the background of the COVID-19 pandemic, the current progress in the development of treatments and prevention of COVID-19 including future aspects of dealing with the pandemic Serves as a timely repository of knowledge on COVID-19 for researchers and medical professionals engaged in its management

Produktinformation

Utgivningsdatum2022-03-04
Mått178 x 254 x 22 mm
Vikt440 g
FormatHäftad
SpråkEngelska
Antal sidor222
FörlagTaylor & Francis Ltd
ISBN9781032040622

Tillhör följande kategorier

Dr. Debmalya Barh is currently a Visiting Full Professor (Titular, Grade-E) at the Department of Genetics, Ecology and Evolution, Institute of Biological Sciences (ICB), Federal University of Minas Gerais (UFMG), Brazil. He is also an honorary Scientist at Institute of Integrative Omics and Applied Biotechnology (IIOAB), India.Dr. Kenneth Lundstrom is currently the CEO of PanTherapeutics in Lausanne, Switzerland.He serves on editorial boards of various journals including Biomedicines and Viruses, and acts as Editor-in-chief for Frontiers in Translational Virology.

Chapter 1 Coronavirus epidemics and the current COVID-19 pandemicChapter 2 Biology of Coronaviruses and Predicted Origin of SARS-CoV-2Chapter 3 Therapeutic Challenges in COVID-19Chapter 4 Prevention and Control Strategies for COVID-19 PandemicChapter 5 Global Focus and Interdisciplinary Approaches in COVID-19 Research and Their OutcomesChapter 6 The evolution of COVID-19 diagnosticsChapter 7 Drug repurposing and novel antiviral drugs for COVID-19 managementChapter 8 Convalescent Plasma and Antibody Therapy in COVID-19Chapter 9 Application Stem Cell and Exosome Based Therapy in COVID-19Chapter 10 Host and Pathogen-Specific Drug Targets in COVID-19Chapter 11 Computational biology and bioinformatics in anti-SARS-CoV-2 drug developmentChapter 12 Nanomaterials in COVID-19 drug developmentChapter 13 Vaccine Development Strategies and the Current Status of COVID-19 VaccinesChapter 14 Clinical trials of COVID-19 therapeutics and vaccines: history, current status, and limitationsChapter 15 Lessons Learned from COVID-19 and Their Implementations for Future Pandemics